Chemically defined generation of human cardiomyocytes

• Published in: Nature methods Vol. 11; no. 8; pp. 855 - 860
• Main Authors: Burridge, Paul W, Matsa, Elena, Shukla, Praveen, Lin, Ziliang C, Churko, Jared M, Ebert, Antje D, Lan, Feng, Diecke, Sebastian, Huber, Bruno, Mordwinkin, Nicholas M, Plews, Jordan R, Abilez, Oscar J, Cui, Bianxiao, Gold, Joseph D, Wu, Joseph C
• Format: Journal Article
• Language: English
• Published: New York Nature Publishing Group US 01.08.2014; Nature Publishing Group
• Subjects: 13/100; 13/106; 13/107; 13/31; 13/51; 14/63; 631/532/1360; 692/308/2171; 9/74; Bioinformatics; Biological Microscopy; Biological Techniques; Biomedical Engineering/Biotechnology; Cardiomyocytes; Cell Differentiation; Chemicals; Culture Media; Cytochemistry; Genetic aspects; Growth; Heart cells; Humans; Induced Pluripotent Stem Cells - cytology; Life Sciences; Methods; Molecular biology; Myocytes, Cardiac - cytology; Proteomics; Stem cells
• ISSN: 1548-7091; 1548-7105; 1548-7105
• DOI: 10.1038/nmeth.2999

A simple, robust, chemically defined method for generating cardiomyocytes from human pluripotent stem cells is described. It should enable the identification of conditions for maturation of these cells. Existing methods for human induced pluripotent stem cell (hiPSC) cardiac differentiation are efficient but require complex, undefined medium constituents that hinder further elucidation of the molecular mechanisms of cardiomyogenesis. Using hiPSCs derived under chemically defined conditions on synthetic matrices, we systematically developed an optimized cardiac differentiation strategy, using a chemically defined medium consisting of just three components: the basal medium RPMI 1640, L -ascorbic acid 2-phosphate and rice-derived recombinant human albumin. Along with small molecule–based induction of differentiation, this protocol produced contractile sheets of up to 95% TNNT2 + cardiomyocytes at a yield of up to 100 cardiomyocytes for every input pluripotent cell and was effective in 11 hiPSC lines tested. This chemically defined platform for cardiac specification of hiPSCs will allow the elucidation of cardiomyocyte macromolecular and metabolic requirements and will provide a minimal system for the study of maturation and subtype specification.